.png)
Speakers
C. Noel Bairey Merz, MD, FACC, FAHA, FESC
Cedars-Sinai Medical Institute, Los Angeles, CA
C. Noel Bairey Merz, MD, holds the Women's Guild Endowed Chair in Women's Health, and is Director of the Barbra Streisand Women's Heart Center, the Linda Joy Pollin Women’s Heart Health Program, the Erika J Glazer Women’s Heart Research Initiative, and the Preventive Cardiac Center at the Cedars-Sinai Heart Institute. She also is Professor of Medicine at Cedars-Sinai Medical Center.
Dr. Bairey Merz's research interests include women and cardiovascular disease, mental stress and heart disease, the role of exercise and stress management in reversing disease, the role of cholesterol and nutrition management in heart disease, and adverse pregnancy outcomes and cardiovascular disease.
A prolific lecturer and member of many professional organizations, Dr. Bairey Merz, has received numerous investigational grants and chairs the National Institutes of Health (NIH)-sponsored WISE (Women's Ischemic Syndrome Evaluation) initiative, investigating potential methods for more effective diagnosis and evaluation of ischemic heart disease in women.
Dr. Bairey Merz has received numerous awards and honors and her extensive scientific publication record spans 425+ scientific papers, 315+ abstracts, myriad book chapters, and countless peer-reviewed journals. Recognized as an authority on the subject of heart disease and stress, she has appeared frequently in print and broacast media.
Dr. Bairey Merz earned her bachelor's degree at the University of Chicago, her medical degree at Harvard University, and completed her residency at the University of California, San Francisco, where she served as Chief Medical Resident before completing fellowships in clinical cardiology and nuclear cardiology at Cedars-Sinai Medical Center.
Edmond M. Cronin, MB BCh BAO, MRCPI, FHRS
Hartford Hospital, Hartford CT
Edmond Cronin is a Cardiac Electrophysiologist at Hartford Healthcare Heart and Vascular Institute, Hartford Hospital, and an Assistant Professor at the University of Connecticut School of Medicine.
A native of Ireland, Dr. Cronin received his medical degree with honors from University College Cork, and completed his electrophysiology training at Cleveland Clinic.
His clinical interests include ventricular tachycardia ablation, atrial fibrillation, and transvenous lead extraction. Dr. Cronin is the author or co-author of more than 30 peer-reviewed articles and book chapters, presents frequently at national and international meetings, and reviews several medical journals. His research focuses on ablation of ventricular arrhythmias and transvenous lead extraction outcomes, and serves as an investigator in several multicenter clinical trials.
Dr. Cronin is a Fellow of the Heart Rhythm Society and currently sits on its Scientific and Clinical Documents Committee. He is a member of the American Heart Association, American College of Cardiology, European Society of Cardiology, European Heart Rhythm Association, Irish Cardiac Society, and the Royal College of Physicians of Ireland. He is also an avid—but not terribly fast—runner.
Jason Gluck, DO
Hartford Hospital, Hartford CT
Jason Gluck is Medical Director of Mechanical Circulatory Support/ECMO, Program Director of the Advanced Heart Failure and Transplant Fellowship, and a Heart Failure and Transplant Specialist at Hartford Hospital. He is also Assistant Professor of Medicine at the University of Connecticut School of Medicine.
Dr. Gluck received his medical degree from the New York College of Osteopathic Medicine. He was a medical resident and cardiovascular disease fellow at New York Hospital Queens, a New York Presbyterian Hospital Weil Medical College of Cornell University affiliate. He completed a subsequent fellowship in advanced heart failure and transplant at New York Presbyterian–Columbia University Medical Center and was among the first to achieve ABIM Board Certification in Advanced Heart Failure and Transplantation.
Dr. Gluck joined Hartford Hospital’s Division of Cardiology in 2010 providing inpatient and outpatient care for advanced heart failure, ventricular assist device (VAD) and cardiac transplant patients. He is a founding member and medical director of the Extracorporeal Membrane Oxygenation (ECMO) program and publishes and speaks internationally on ECMO and acute cardiogenic shock.
Dr. Gluck’s clinical interest is in acute shock and mechanical circulatory support, pre-hospital emergency medical care and medical simulation. Dr. Gluck invented VLAD, a Left Ventricular Assist Device medical simulator, in his garage—for training patients, family members, and healthcare providers on LVADs and their potential emergencies.
Dr. Gluck recently co-chaired a white paper published in Circ for the American Heart Association on the emergent care for a VAD patient with cardiac arrest and is currently an international lead for a white paper for management of patients with acute cardiopulmonary failure for the International Society for Heart and Lung Transplant.
Jonathan A. Hammond, Jr., MD
Hartford Hospital, Hartford CT
Dr. Hammond is Assistant Clinical Professor of Surgery at the University of Connecticut School of Medicine and Surgical Director of the Hartford Hospital Heart Transplant and Mechanical Circulatory Programs.
After graduating from Williams College and Harvard Medical School, he completed the Hartford Hospital/University of Connecticut Integrated General Surgery Residency in 1989.
He joined the Division (now Department) of Cardiac Surgery at Hartford Hospital in 1991, following his Cardiac Surgery Residency at the Medical College of Wisconsin.
He is a member of the International Society for Heart and Lung Transplantation, the Society of Thoracic Surgeons, and the International Society for Minimally Invasive Cardiac Surgery.
David J. Maron, MD, FACC, FAHA
Stanford University School of Medicine, Stanford, CA
Dr. Maron received his undergraduate degree from Stanford University and his medical degree from the University of Southern California. He trained in internal medicine at UCLA. He was a Robert Wood Johnson Clinical Scholar, a preventive cardiology fellow, and subsequently a cardiology fellow at Stanford University. After two years in private practice in Santa Monica, he moved to Nashville in 1993 to join the faculty at Vanderbilt as Assistant Professor and Director of Preventive Cardiology. At Vanderbilt he rose through the ranks to Professor of Medicine, and received a secondary appointment as Professor of Emergency Medicine. The latter was due to his role as director of Emergency Cardiology and of the Vanderbilt Chest Pain Unit.
He returned to Stanford in 2014 where he serves as Clinical Professor of Medicine, Director of Preventive Cardiology, and Interim Chief of the Stanford Prevention Research Center.
Dr. Maron’s research interests include primary and secondary prevention of coronary heart disease. He was a member of the executive committee of the COURAGE trial, a landmark trial that found that stenting was not superior to optimal medical therapy for preventing myocardial infarction and death. He is currently the Co-Chair of the ISCHEMIA trial, an NIH-funded study comparing the effectiveness of two initial management strategies–conservative (optimal medical therapy alone) versus invasive (optimal medical therapy plus cardiac catheterization and revascularization)–in 5,179 participants with stable coronary disease and at least moderate ischemia on stress testing.
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI
Icahn School of Medicine at Mount Sinai, New York, NY
Roxana Mehran, Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, is internationally renowned in the field of interventional cardiovascular disease.
As Director of Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has developed a globally respected data and clinical coordination center.
A prolific researcher and author, she has served as principal investigator for numerous large global studies, developed risk scores for bleeding and acute kidney injury, and authored more than 800 peer-reviewed articles. Dr. Mehran has received numerous prestigious awards, most recently the 2017 Bernadine Healy Leadership in Women’s CV Disease Award, and just this May, the 2018 Wenger Award for Excellence in Medical Leadership. She is co-founder of the Academic Research Consortium (ARC) and SCAI Women in Innovation (SCAI-WIN), and a founding physician of the Cardiovascular Research Foundation, where she is currently Chief Scientific Officer.
Prior to her position at Mount Sinai, Dr. Mehran held appointments at Columbia University Medical Center and Washington Hospital Center. She completed internal medicine training at the University of Connecticut and fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center.
Kim Allan Williams, MD, MACC, MASNC, FAHA, FESC
Stanford University School of Medicine, Stanford, CA
Kim Williams serves as Chief of the Division of Cardiology and James B. Herrick Endowed Professor of Medicine and Cardiology at Rush University Medical Center. He has served as President of the American Society of Nuclear Cardiology (ASNC, 2004-2005), Chairman of the Board of the Association of Black Cardiologists (ABC, 2008-2010), and President of the American College of Cardiology (ACC, 2015-2016).
Prior to coming to Rush University, Dr. Williams was Chairman of the Division of Cardiology at Wayne State University School of Medicine in Detroit, where he started the Urban Cardiology Initiative. This continued at Rush in Chicago, as he initiated the HEART Program (Helping Everyone Assess Risk Today) to screen churches and community groups for heart disease and stroke risk.
Dr. Williams has published numerous peer-reviewed articles, monographs, book chapters, editorials, and review articles. He has served on many committees and boards for the American Heart Association, the American Medical Association, ASNC, ACC, and ABC.
Dr. Williams received his medical degree from the University of Chicago’s Pritzker School of Medicine. He completed his internal medicine residency at Emory University and overlapping fellowships in cardiology at the University of Chicago in clinical pharmacology and nuclear medicine.